BLOOD FOLLICLE STIMULATING HORMONE INCREASED side effect
What is BLOOD FOLLICLE STIMULATING HORMONE INCREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
BLOOD FOLLICLE STIMULATING HORMONE INCREASED and Recently Reported Side Effects
BLOOD FOLLICLE STIMULATING HORMONE INCREASED and 15 most Active Side Effect polls
BLOOD FOLLICLE STIMULATING HORMONE INCREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with BLOOD FOLLICLE STIMULATING HORMONE INCREASED
ACITRETIN BLEOMYCIN CISPLATIN DEPAKENE FEMCON IMATINIB IRINOTECAN LUPRON MIRENA SEROQUEL THALOMID ULTRAMSeroquel Side Effects Report #5673113-4
Physician from NETHERLANDS reported SEROQUEL problem on Mar 17, 2008. Female patient, weighting 180.8 lb, was diagnosed with psychotic disorder, insomnia and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, blood luteinising hormone increased, . SEROQUEL dosage: unknown. During the same period patient was treated with CISORDINOL, TEMESTA, ALPRAZOLAM. Patient recovered.
Thalomid Side Effects Report #5618513-3
THALOMID problem was reported by a Physician from UNITED STATES on Jan 28, 2008. Female patient, 35 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, blood human chorionic gonadotropin increased, bone marrow transplant, . THALOMID dosage: 200 MG, 1 IN 1 D, ORAL; 200 MG, 4 IN 1 D, ORAL. Patient recovered.
Femcon Side Effects Report #5452118-2
Physician from UNITED STATES reported FEMCON FE problem on Aug 28, 2007. Female patient was treated with FEMCON FE. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, endometrial hypertrophy, ovarian cyst, . FEMCON FE dosage: 0.4MG/35 MCG, ORAL. Patient recovered.
Depakene Side Effects Report #5453307-3
DEPAKENE problem was reported by a Health Professional from FRANCE on Sept 04, 2007. Male patient, 20 years of age, was diagnosed with epilepsy, vitamin supplementation and was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, blood testosterone decreased, fall, hyponatraemia, increased appetite, vertebral injury, . DEPAKENE dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE. Patient recovered.
Mirena Side Effects Report #5407785-6
Consumer or non-health professional from GERMANY reported MIRENA problem on July 30, 2007. Female patient, 50 years of age, weighting 143.3 lb, was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, breast cancer in situ, . MIRENA dosage: unknown. Patient was hospitalized. Patient recovered.
Mirena Side Effects Report #5382353-3
MIRENA problem was reported by a Consumer or non-health professional from GERMANY on July 04, 2007. Female patient, 50 years of age, was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, breast cancer female, . MIRENA dosage: unknown. Patient was hospitalized. Patient recovered.
Mirena Side Effects Report #5382353-3
Consumer or non-health professional from GERMANY reported MIRENA problem on July 04, 2007. Female patient, 50 years of age, was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, breast cancer female, . MIRENA dosage: unknown. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5769070-2
IRINOTECAN problem was reported by a Physician from JAPAN on May 29, 2008. Female patient, 47 years of age, was diagnosed with cervix carcinoma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, blood luteinising hormone increased, diarrhoea, hot flush, malaise, menopausal disorder, ovarian disorder, . IRINOTECAN dosage: 4 DOSES, TOTAL DOSE 430 MG, INJECTION NOS. During the same period patient was treated with NEDAPLATIN. Patient recovered.
Lupron Side Effects Report #5692746-2
Physician from UNITED STATES reported LUPRON DEPOT problem on Mar 24, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer and was treated with LUPRON DEPOT. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, blood luteinising hormone increased, hemianopia heteronymous, pituitary tumour benign, . LUPRON DEPOT dosage: 7.5 MG, 1 IN 1 M, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.
Acitretin Side Effects Report #5346182-9
ACITRETIN problem was reported by a Physician from SWEDEN on May 18, 2007. Male patient, 35 years of age, was diagnosed with exfoliative rash and was treated with ACITRETIN. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, infertility, sperm count decreased, spermatozoa progressive motility decreased, . ACITRETIN dosage: 10 MG; ; PO. Patient recovered.
Ultram Side Effects Report #5662413-X
Consumer or non-health professional from UNITED STATES reported ULTRAM problem on Mar 04, 2008. Female patient, weighting 120.0 lb, was diagnosed with pain and was treated with ULTRAM. After drug was administered, patient experienced the following problems/side effects: anovulatory cycle, blood follicle stimulating hormone increased, constipation, ovarian cyst, . ULTRAM dosage: unknown. Patient recovered.
Imatinib Side Effects Report #5669324-4
IMATINIB problem was reported by a Health Professional from GREECE on Mar 05, 2008. Female patient, 28 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, blood follicle stimulating hormone increased, muscle spasms, oligomenorrhoea, ovarian failure, skin discolouration, ultrasound ovary abnormal, . IMATINIB dosage: 400 MG/D. Patient recovered.
Bleomycin Side Effects Report #5262371-6
Consumer or non-health professional from JAPAN reported BLEOMYCIN problem on Feb 23, 2007. Male patient, 32 years of age, was diagnosed with testis cancer, seminoma and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: azoospermia, blood follicle stimulating hormone increased, blood luteinising hormone increased, . BLEOMYCIN dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, CARBOPLATIN, IFOSFAMIDE. Patient recovered.
Cisplatin Side Effects Report #5277976-6
CISPLATIN problem was reported by a Consumer or non-health professional from JAPAN on Mar 07, 2007. Male patient, 32 years of age, was diagnosed with testis cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: azoospermia, blood follicle stimulating hormone increased, blood luteinising hormone increased, . CISPLATIN dosage: ?? (20 MG/M2) ??. During the same period patient was treated with ETOPOSIDE, BLEOMYCIN, CARBOPLATIN, IFOSFAMIDE. Patient recovered.